Glue Advertising LLC and The Rani Trust join Calla Lily Clinical Care cap table

Glue Advertising LLC and The Rani Trust have joined the cap table of Calla Lily Clinical Care Ltd, a London-based developer of intravaginal drug delivery technologies. Founded in 2021, the company engineers medical devices to address clinical needs such as fertility support, pregnancy management, and the restoration of the vaginal microbiome.

Glue Advertising LLC is the largest new entrant, joining the register with 43,775 ordinary shares. The Rani Trust also joined the cap table during this period (ending 23 May 2026) with a holding of 20,811 ordinary shares. The appearance of multiple new investors may signal a recent investment round.

These new shareholders join a cap table that includes several established investors. Odin Investments Ltd (Nom) remains the largest shareholder with 478,479 shares. Other existing shareholders that maintain their positions include Kotzubei-Beckmann Trust UDT with 260,000 shares, Lefa Investments Ltd with 151,630 shares, and Martinez-Igarashi Trust with 135,840 shares. Corner Capital Group LLC holds 133,340 shares, while Little Tree Health Solutions LLC and Investkonsult Sweden AB retain holdings of 66,667 and 35,544 shares respectively. The filing does not list other UK companies backed by the new entrants.